Patents

Company announces plans to contest patent infringement action by Abbott

Published in Obesity and Diabetes Week, September 12th, 2005

DexCom Inc., (DXCM) announced that Abbott Diabetes Care, Inc., filed an action alleging patent infringement against DexCom in the United States District Court for the District of Delaware.

DexCom believes the complaint is without merit and intends to vigorously contest the action. DexCom believes its technology, which was developed independently, is clearly differentiated from that described in the patents cited by Abbott in the complaint.

DexCom states it further believes the complaint filed by Abbott is largely an attempt by a much larger and established company to intimidate and distract DexCom, a much smaller company, from commercializing its STS...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week

Source: Obesity and Diabetes Week (2005-09-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry